Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01741259 · ClinicalTrials.gov registry record · NA
A Comparison of Meperidine for Post-Cesarean Analgesia: Bolus Versus Infusion and Bolus
A NA study, sponsored by Mercy Research.
- Completed
- Registry status
- NA
- Development phase
- 273
- Enrollment target
NCT01741259 is a NA study that has completed, run by Mercy Research. The registered enrollment target is 273 participants.
The verdict
NCT01741259, a NA study, has completed, sponsored by Mercy Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 273 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if epidural meperidine administered by patient-controlled bolus button is equivalent to a low dose infusion plus patient-controlled bolus.
Interventions
- DRUG Meperidine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 273 participants |
| Start Date | 2013-08 |
| Est. Completion | 2015-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01741259
The ClinicalTrials.gov registry entry for NCT01741259 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 273 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mercy Research, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Meperidine is the first listed.
NCT01741259 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01741259 about?
NCT01741259 is a clinical study titled "A Comparison of Meperidine for Post-Cesarean Analgesia: Bolus Versus Infusion and Bolus". The purpose of this study is to determine if epidural meperidine administered by patient-controlled bolus button is equivalent to a low dose infusion plus patient-controlled bolus.
What is the current status of trial NCT01741259?
This trial is currently completed. It is a NA study. The enrollment target is 273 participants. The study started on 2013-08. Estimated completion is 2015-04.
What interventions are being tested in trial NCT01741259?
The interventions under investigation include: Meperidine (DRUG).
Who is sponsoring clinical trial NCT01741259?
This trial is sponsored by Mercy Research, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.